Net Cash Provided by (Used in) Operating Activities |
2.61M |
USD |
+169% |
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
59.5K |
USD |
|
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-2.36M |
USD |
-34.2% |
Q3 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
FY 2024 |
Common Stock, Shares, Issued |
3.13M |
shares |
0% |
Q2 2024 |
FY 2024 |
Common Stock, Par or Stated Value Per Share |
0.33 |
USD/shares |
0% |
Q2 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
316K |
USD |
|
Q3 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.35M |
USD |
+58.3% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
974K |
USD |
+192% |
Q2 2024 |
FY 2024 |
Depreciation |
119K |
USD |
-1.29% |
Q3 2023 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
2.23M |
USD |
+4315% |
Q3 2023 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
5.82M |
USD |
+58.4% |
Q2 2024 |
FY 2024 |
Property, Plant and Equipment, Gross |
17.2M |
USD |
+4.68% |
Q2 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
-214K |
USD |
-12499% |
Q3 2023 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
888K |
USD |
|
Q1 2024 |
Q3 2024 |
Share-based Payment Arrangement, Expense |
284K |
USD |
+24.9% |
Q2 2024 |
FY 2024 |